Centrex (ASX:CXM) starts shipping with phosphate rock prices booming
Centrex (ASX: CXM), developer of the Ardmore Phosphate Rock Project in northwestern Queensland, released a project update this morning.
The company is now shipping rock from Ardmore to Townsville at a rate of 10,000 tonnes per month and it intends to get this to 30,000 tonnes a month during the course of calendar 2023. It also expects that its first phosphate rock exports will be made next month.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
Phosphate rock price keeps on rising
Encouragingly, the price of phosphate rock as per the benchmark price, which is rock FOB North Africa as measured by the World Bank, has now reached US$320 a tonne, as against the mere US$125 a tonne at which Centrex did its Definitive Feasibility Study for what it is now calling ‘Ardmore 2.0’ where 800,000 tonnes per annum are produced .
That study placed a pre-tax NPV of $166m on Ardmore on a 10% discount rate. Centrex is currently doing Front End Engineering and Design on Ardmore 2.0 ahead of a Final Investment Decision (FID). In the meantime, the company is also contemplating an expansion of the original pilot plant, which it calls Ardmore Stage 1.5 and expects to be able to give an update on this in the near future.
Centrex price target of $0.21 at a minumum
Our minimum target price for CXM, one of our Stocks Down Under Concierge stocks, remains 21 cents.
Centrex (ASX:CXM) price chart, log scale (Source: Tradingview)
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.

Blog Categories
Get the Latest Insider Trades on ASX!
Recent Posts
These 2 ASX Healthcare Stocks Are Quietly Cashing In on the AI Revolution
ASX Healthcare Stocks Benefiting From AI Artificial intelligence is reshaping healthcare faster than most investors realise. Hospital imaging systems, pathology…
Which ASX Uranium Stocks Benefit Most From the Iran War and the Hormuz Oil Crisis?
ASX Uranium Stocks to Watch This Week Brent crude is sitting just above US$111 a barrel as of this morning,…
Telix pharmaceuticals (ASX: TLX) A$230m Quarter Puts Guidance Back In Play
Is Telix in Turnaround Mode or Dead-Cat Bounce? The question investors are now asking about Telix pharmaceuticals is whether the…